Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1008

1.

A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.

Grassi MC, Enea D, Ferketich AK, Lu B, Nencini P.

Nicotine Tob Res. 2009 Sep;11(9):1114-21. doi: 10.1093/ntr/ntp110. Epub 2009 Aug 4.

PMID:
19654237
2.

A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.

McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Fiore MC, Baker TB.

Nicotine Tob Res. 2008 Apr;10(4):717-29. doi: 10.1080/14622200801968343.

PMID:
18418793
3.

Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.

Rovina N, Nikoloutsou I, Katsani G, Dima E, Fransis K, Roussos C, Gratziou C.

Ther Adv Respir Dis. 2009 Dec;3(6):279-87. doi: 10.1177/1753465809350653.

PMID:
19934280
4.

Offering telephone counseling to smokers using pharmacotherapy.

Boyle RG, Solberg LI, Asche SE, Boucher JL, Pronk NP, Jensen CJ.

Nicotine Tob Res. 2005 Apr;7 Suppl 1:S19-27.

PMID:
16036266
5.

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.

Dalsgareth OJ, Hansen NC, Søes-Petersen U, Evald T, Høegholm A, Barber J, Vestbo J.

Nicotine Tob Res. 2004 Feb;6(1):55-61.

PMID:
14982688
6.

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.

Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP.

Nicotine Tob Res. 2009 Jun;11(6):663-9. doi: 10.1093/ntr/ntp047. Epub 2009 Apr 24.

PMID:
19395688
7.

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.

Johnston JA, Fiedler-Kelly J, Glover ED, Sachs DP, Grasela TH, DeVeaugh-Geiss J.

Nicotine Tob Res. 2001 May;3(2):131-40.

PMID:
11403727
8.

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.

Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C.

Nicotine Tob Res. 2004 Feb;6(1):27-37.

PMID:
14982685
9.

Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?

Chatkin JM, Mariante de Abreu C, Haggsträm FM, Wagner MB, Fritscher CC.

Addiction. 2004 Jun;99(6):778-84.

PMID:
15139876
10.

Smoking cessation treatment in a real-life setting: the Greek experience.

Rovina N, Nikoloutsou I, Dima E, Michailidou M, Roussos C, Gratziou C.

Ther Adv Respir Dis. 2007 Dec;1(2):93-104. doi: 10.1177/1753465807085799.

PMID:
19124351
11.

A multi-level analysis of non-significant counseling effects in a randomized smoking cessation trial.

McCarthy DE, Piasecki TM, Jorenby DE, Lawrence DL, Shiffman S, Baker TB.

Addiction. 2010 Dec;105(12):2195-208. doi: 10.1111/j.1360-0443.2010.03089.x. Epub 2010 Sep 15.

12.

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R.

Eur Heart J. 2003 May;24(10):946-55.

13.

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.

Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, Goff DC.

J Clin Psychiatry. 2004 Mar;65(3):307-11; quiz 452-3.

PMID:
15096068
14.

A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation.

Glover ED, Glover PN, Sullivan CR, Cerullo CL, Hobbs G.

Am J Health Behav. 2002 Sep-Oct;26(5):386-93.

PMID:
12206448
15.

Clinical effectiveness of sustained-release bupropion and behavior therapy for tobacco dependence in a clinical setting.

Earles J, Folen RA, Ma M, Kellar M, Geralde R, Dydek Co.

Mil Med. 2002 Nov;167(11):923-5.

PMID:
12448619
16.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
17.

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.

Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC.

Nicotine Tob Res. 2001 Nov;3(4):397-403.

PMID:
11694208
18.
19.
20.

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

Addiction. 2004 Sep;99(9):1206-18.

PMID:
15317642
Items per page

Supplemental Content

Write to the Help Desk